Terrill Dicki
Aug 28, 2025 19:56
INJ climbs 3.52% to $13.83 as traders hunt for oversold bounce following devastating 22% regulatory crash and exchange delistings that hammered the token.
Quick Take
• INJ currently trading at $13.83 (+3.52% in 24h)
• Injective’s RSI sits at neutral 49.51, suggesting oversold bounce potential
• Recent 22% crash triggered by regulatory scrutiny and major exchange delistings
What’s Driving Injective Price Today?
Injective is attempting a modest recovery after facing its most challenging week in months. The primary catalyst behind recent price action remains the devastating regulatory news from August 27, when INJ crashed 22.22% following reports of regulatory scrutiny, staff layoffs, and product development pauses. Major exchanges delisted the token over compliance issues, creating serious liquidity concerns.
This regulatory hammer blow followed an earlier 30.85% plunge on August 13, when INJ corrected sharply from its previous rally that had seen gains of over 2250% in the prior month. The combination of profit-taking from earlier gains and mounting regulatory pressure created a perfect storm for Injective holders.
Today’s 3.52% bounce appears to be technical in nature, with bargain hunters stepping in after the token found support near key levels. However, the regulatory overhang continues to weigh heavily on sentiment, and traders remain cautious about the platform’s operational stability moving forward.
INJ Technical Analysis: Mixed Signals Emerge
Injective technical analysis reveals a token caught between conflicting forces. The most encouraging signal comes from Injective’s RSI at 49.51, sitting in neutral territory after being heavily oversold during the recent crash. This INJ RSI reading suggests the worst of the selling pressure may have temporarily subsided.
The moving average picture tells a more complex story. INJ price currently trades below its 7-day SMA at $13.92 and 20-day SMA at $14.26, indicating short-term bearish momentum. However, the token remains above its 200-day SMA at $11.86, suggesting the longer-term uptrend hasn’t been completely broken.
Injective’s MACD histogram at -0.1410 shows bearish momentum persists, though the magnitude appears to be weakening. The Stochastic indicators (%K at 32.95, %D at 23.70) suggest INJ is approaching oversold territory, potentially setting up for a bounce.
Based on Binance spot market data, Injective’s Bollinger Bands position at 0.3680 indicates the token is trading in the lower portion of its recent range, with room to move higher toward the middle band at $14.26.
Injective Price Levels: Key Support and Resistance
Critical Injective support levels have emerged around $12.67 for immediate support, with stronger backing at $10.83. The recent bounce from near the $13.17 low suggests buyers are defending these levels aggressively.
On the upside, INJ resistance appears formidable at $16.55, which represents both immediate and strong resistance according to technical levels. This level roughly aligns with where the token peaked before the regulatory selloff began.
The INJ/USDT pair’s current position near $13.83 puts it roughly at the pivot point of $13.71, suggesting traders are in a wait-and-see mode. A decisive break above $14.26 (the 20-day SMA) could signal that the worst is behind Injective, while a fall below $12.67 would likely trigger another leg down toward the strong support at $10.83.
Should You Buy INJ Now? Risk-Reward Analysis
The risk-reward profile for INJ price depends heavily on your risk tolerance and trading timeframe. For aggressive traders, the current setup offers a potential oversold bounce play with stops below $12.67 and targets near $14.26-$15.89.
Conservative investors should wait for clearer resolution of the regulatory issues before considering positions. The exchange delistings represent a fundamental challenge that technical analysis cannot address, and further regulatory actions could trigger additional selling regardless of chart patterns.
Swing traders might consider a scaled approach, buying small positions near current levels with additional buying planned if INJ price falls toward the $12.67 support. This strategy allows participation in any bounce while limiting downside exposure.
The daily ATR of $1.21 indicates significant volatility remains in play, meaning position sizing should be reduced accordingly. Given the regulatory uncertainty, risk management becomes even more critical than usual.
Conclusion
INJ price shows early signs of stabilization at $13.83, but the regulatory cloud hanging over Injective makes any recovery fragile. While technical indicators suggest oversold conditions that could fuel a short-term bounce, traders should remain cautious until there’s clarity on the exchange delisting issues and regulatory compliance matters. The next 24-48 hours will be crucial in determining whether this modest recovery can gain momentum or if another wave of selling awaits.
Image source: Shutterstock
Credit: Source link
